12-8854772-C-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000299698.12(A2ML1):c.2713-8C>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00138 in 1,614,130 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000299698.12 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
A2ML1 | NM_144670.6 | c.2713-8C>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000299698.12 | NP_653271.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
A2ML1 | ENST00000299698.12 | c.2713-8C>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_144670.6 | ENSP00000299698 | P1 | |||
A2ML1 | ENST00000539547.5 | c.1240-8C>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 2 | ENSP00000438292 | |||||
A2ML1 | ENST00000541459.5 | c.1363-8C>A | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 2 | ENSP00000443174 |
Frequencies
GnomAD3 genomes AF: 0.00209 AC: 318AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00172 AC: 429AN: 249404Hom.: 3 AF XY: 0.00168 AC XY: 228AN XY: 135330
GnomAD4 exome AF: 0.00130 AC: 1907AN: 1461824Hom.: 11 Cov.: 32 AF XY: 0.00129 AC XY: 938AN XY: 727206
GnomAD4 genome AF: 0.00209 AC: 318AN: 152306Hom.: 0 Cov.: 32 AF XY: 0.00267 AC XY: 199AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 04, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Otitis media Uncertain:1
Uncertain significance, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Otitis media, susceptibility to Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Santos-Cortez Lab, University of Colorado School of Medicine | Apr 25, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 22, 2019 | Variant summary: A2ML1 c.2713-8C>A alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0017 in 249404 control chromosomes in the gnomAD database, including 3 homozygotes. The observed variant frequency is approximately 430-fold over the estimated maximal allele frequency expected for a pathogenic variant in A2ML1 causing Noonan Syndrome phenotype (4e-06), strongly suggesting that the variant is benign. Co-occurrence with another pathogenic variant has been reported (PTPN11 c.923A>C, p.N308T; internal sample), providing supporting evidence for a benign role. To our knowledge, there are no reports of c.2713-8C>A in individuals affected with Noonan Syndrome and no experimental evidence demonstrating an impact on protein function in the literature. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Two laboratories cited the variant as benign and one cited the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as benign. - |
A2ML1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 01, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at